[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Biobeats99 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1687188043390697472.png) @Biobeats99 Luca Research Investment Club

Biotech companies are sharing updates on their research and development progress at various conferences, including ESMO. Several firms, such as Cantor Fitzgerald, Jefferies, and Bank of America, are providing analysis and insights on the biotech sector. Key areas of focus include advancements in cancer treatment, gene therapy, and rare diseases.

### Engagements: XXX [#](/creator/twitter::1687188043390697472/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1687188043390697472/c:line/m:interactions.svg)

- X Week XXXXX +24%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +628%

### Mentions: XX [#](/creator/twitter::1687188043390697472/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1687188043390697472/c:line/m:posts_active.svg)

- X Week XXX +15%
- X Month XXX +20%
- X Months XXX +137%
- X Year XXX +1,258%

### Followers: XXX [#](/creator/twitter::1687188043390697472/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1687188043390697472/c:line/m:followers.svg)

- X Week XXX +0.31%
- X Month XXX +1.60%
- X Months XXX +28%
- X Year XXX +111%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1687188043390697472/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1687188043390697472/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  XXXXX% [stocks](/list/stocks)  XX% [cryptocurrencies](/list/cryptocurrencies)  XXXXX% [countries](/list/countries)  XXXX% [social networks](/list/social-networks)  XXXX% [technology brands](/list/technology-brands)  XXXX% [automotive brands](/list/automotive-brands)  XXXX%

**Social topic influence**
[$rxrx](/topic/$rxrx) #11, [$kymr](/topic/$kymr) #35, [$beam](/topic/$beam) #22, [$dyn](/topic/$dyn) #12, [$ntla](/topic/$ntla) #8, [$bmrn](/topic/$bmrn) #6, [$axsm](/topic/$axsm) #9, [$nuvl](/topic/$nuvl) #5, [$crsp](/topic/$crsp) #16, [$alny](/topic/$alny) #13

**Top assets mentioned**
[Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)](/topic/$rxrx) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [BEAM (BEAM)](/topic/$beam) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [Nuvalent, Inc. Class A Common Stock (NUVL)](/topic/$nuvl) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [CG Oncology, Inc. Common stock (CGON)](/topic/$cgon) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Vertex Protocol (VRTX)](/topic/$vrtx) [Taraxa (TARA)](/topic/$tara) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Bluefin (BLUE)](/topic/$blue) [Goldman Sachs (GS)](/topic/goldman-sachs) [Immunogen Inc (IMGN)](/topic/$imgn) [uniQure N.V. (QURE)](/topic/$qure) [Amgen, Inc. (AMGN)](/topic/$amgn) [Denali Therapeutics Inc. Common Stock (DNLI)](/topic/$dnli) [Biogen Inc (BIIB)](/topic/$biib) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Cogent Biosciences, Inc. Common Stock (COGT)](/topic/$cogt) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [SuperRare (RARE)](/topic/$rare) [Adverum Biotechnologies, Inc. Common Stock (ADVM)](/topic/$advm) [Supernus Pharmaceuticals, Inc. (SUPN)](/topic/$supn) [Sage Therapeutics, Inc (SAGE)](/topic/$sage) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Disc Medicine, Inc. Common Stock (IRON)](/topic/$iron) [Acadia Pharmaceuticals Inc. (ACAD)](/topic/$acad) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [Dawn Protocol (DAWN)](/topic/$dawn) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [AbbVie Inc (ABBV)](/topic/$abbv) [Johnson & Johnson (JNJ)](/topic/$jnj) [Insmed, Inc. (INSM)](/topic/$insm) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Eli Lilly and Company (LLY)](/topic/$lly) [Danaher Corporation (DHR)](/topic/$dhr) [Novo-Nordisk (NVO)](/topic/$nvo) [Bank of America (BAC)](/topic/bank-of-america) [Arcutis Biotherapeutics, Inc. Common Stock (ARQT)](/topic/$arqt) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve)
### Top Social Posts
Top posts by engagements in the last XX hours

"Barclays CLLS - 3Q25 incremental; eyes on ASH updates Full report in bio $CLLS $LEGN $IMCR $KURA $IDYA $RVMD $TNGX $ZYME $MRUS $IMNM $NUVL $RPTX $ALXO $PYXS $COGT $CRNX $SNDX $IRON $NRIX $REPL $ANAB $VTYX $INSM $ARQT $PRAX $RARE $FGEN $GLPG $NBIX $ACAD $VKTX"  
[X Link](https://x.com/Biobeats99/status/1987623680311267752)  2025-11-09T20:49Z XXX followers, XXX engagements


"Wedbush Initial clinical data for WVE-007 demonstrates a transformative therapeutic profile potentially opening a significant new market in neuromuscular and neurological disorders. Full report in Bio $WVE $IONS $ALNY $BMRN $RARE $NTLA $CRSP $BEAM $EDIT $SRPT $KYMR $RXRX"  
[X Link](https://x.com/Biobeats99/status/1998056515056349210)  2025-12-08T15:46Z XXX followers, XXX engagements


"TVTX: Updated KDIGO guidelines position Filspari as 1L treatment option in IgAN; should drive uptake w/ lighter REMS Full report in Telegram (in the header)☝ $TVTX $RARE $FOLD $ALNY $BMRN $VKTX"  
[X Link](https://x.com/Biobeats99/status/1968893526827036702)  2025-09-19T04:22Z XXX followers, XXX engagements


"Cantor Fitzgerald Cantor/EPRX: Dose Response Just Keeps Getting Better with EP-104GI in EoE Full report in Telegram (in bio)☝ (Tickers: $EPRX $IMVT $RVNC $DAWN $BMRN $REGN)"  
[X Link](https://x.com/Biobeats99/status/1973751058263638481)  2025-10-02T14:04Z XXX followers, XXX engagements


"U.S. Small & Mid Cap Biotechnology: Key Takeaways from KOL Call on Heme Malignancies: Read-through for Nurix (NRIX) BeOne (ONC) and Incyte (INCY) Full report in Telegram (in bio)👆 $NRIX $ONC $INCY $BMRN $SRPT $ARWR $ALNY $IONS $BLUE $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE"  
[X Link](https://x.com/Biobeats99/status/1979055787205890525)  2025-10-17T05:24Z XXX followers, XXX engagements


"TD Cowen QUICK TAKE - SMMT - Mgmt Dinner Highlights: One Step Closer To Transforming NSCLC & Onc At-Large Full report in Telegram (in bio)👆 $SMMT $AKESO $LEGN $AMGN $BMRN $SRPT $IONS $ALNY $ARWR $BLUE $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $ABEO $PGEN $DNLI $FATE $SGMO"  
[X Link](https://x.com/Biobeats99/status/1980301493187260848)  2025-10-20T15:54Z XXX followers, XXX engagements


"JP Morgan China Healthcare: Key takeaways from 11th batch of national centralized drug procurement Full report in bio $ZLAB $IMAB $AKESO $EGRNF $HLVX $ALNY $ARWR $IONS $BLUE $BMRN $SRPT $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $PGEN $DNLI $FATE $ADVM $VERV $PRAX $GLPG"  
[X Link](https://x.com/Biobeats99/status/1983494188692836663)  2025-10-29T11:20Z XXX followers, XXX engagements


"Goldman Sachs KeyMed A key player in China's booming immunology; Initiate at Buy XX pages Full report in bio $ZLAB $IMAB $AKESO $EGRNF $HLVX $ARWR $ALNY $IONS $BLUE $BMRN $SRPT $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $PGEN $DNLI $FATE $ADVM"  
[X Link](https://x.com/Biobeats99/status/1985479139009196483)  2025-11-03T22:48Z XXX followers, XXX engagements


"Goldman Sachs Henlius Biotech Next-gen IO-ADC to lead pipeline globalization; initiate at Buy Full report in bio $2696.HK $ZLAB $IMAB $AKESO $EGRNF $HLVX $ARWR $ALNY $IONS $BLUE $BMRN $SRPT $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $PGEN $DNLI"  
[X Link](https://x.com/Biobeats99/status/1985479647875023206)  2025-11-03T22:50Z XXX followers, XXX engagements


"Goldman Sachs China Healthcare: Biotechnology: From Survive to Thrive - Deep-dive on China's small-cap biotech; initiate on Abbisko at Buy Full report in bio $2256.HK $ZLAB $IMAB $AKESO $EGRNF $HLVX $2162.HK $2696.HK $ARWR $ALNY $IONS $BLUE $BMRN $SRPT $VRTX $EDIT $CRSP"  
[X Link](https://x.com/Biobeats99/status/1985479855480221740)  2025-11-03T22:51Z XXX followers, XXX engagements


"Goldman Sachs Phoenix Education Partners (PXED): Leading Online University with Focus on Student Outcomes and Sustainable Growth; Initiate at Neutral Full report in bio $PXED $CHGG $COUR $LRN $STRA $LOPE $APEI $PRDO $BFAM $TWOU $PSO $RELX $UDMY $DUOL $BIDU $META $GOOGL"  
[X Link](https://x.com/Biobeats99/status/1985481049694998576)  2025-11-03T22:55Z XXX followers, XXX engagements


"Goldman Sachs Neptune Holdings: A Flood Insurance Leader with a Unique Market Growth + Market Share Gains Story; Initiate Buy Full report in bio $NP $TRV $CB $ALL $PGR $HIG $AIG $WRB $CINF $AFG $ORI $RNR $RE $EG $MKL $RLI $ACGL $KNSL $SIGI $MCY $BRO $AJG $WTW $MMC $SPGI"  
[X Link](https://x.com/Biobeats99/status/1985481633802437043)  2025-11-03T22:58Z XXX followers, XXX engagements


"JP Morgan Webinar on X Dec - US Pharma & Biotech Outlook: Global Potential of China Innovative Drugs Full video in bio $ZLAB $IMAB $AKESO $EGRNF $HLVX $ARWR $ALNY $IONS $BLUE $BMRN $SRPT $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $PGEN $DNLI $FATE $ADVM $VERV $PRAX $GLPG"  
[X Link](https://x.com/Biobeats99/status/1988529857672736916)  2025-11-12T08:50Z XXX followers, XXX engagements


"Jefferies Deep Dive ALX Oncology (ALXO BUY): Focused High-Value Pipeline on Biomarker IO and ADC - Initiate at BUY PT $X Full report in bio $ALXO $IMCR $LEGN $KURA $IDYA $RVMD $TNGX $ZYME $MRUS $IMNM $NUVL $RPTX $PYXS $COGT $CRNX $SNDX $IRON $NRIX $REPL $ANAB $VTYX $INSM"  
[X Link](https://x.com/Biobeats99/status/1989471354614321510)  2025-11-14T23:11Z XXX followers, XXX engagements


"LifeSci Capital Deep Dive ADAG (OUTPERFORM $XXXX PT): Realizing the True Potential of CTLA-4; Initiating at OUTPERFORM and $X PT Full report in bio $ADAG $IMCR $LEGN $KURA $IDYA $RVMD $TNGX $ZYME $MRUS $IMNM $NUVL $RPTX $ALXO $PYXS $COGT $CRNX $SNDX $IRON $NRIX $REPL $ANAB"  
[X Link](https://x.com/Biobeats99/status/1989471687851872309)  2025-11-14T23:13Z XXX followers, XXX engagements


"Goldman Sachs SSE LN: SSE Deep dive: to raise or not to raise BUY United Kingdom Full report in bio $SSE $NGG $CNA $DAX $ENEL $IBE $ORSTED $RWE $VOD $BTI $BP $SHEL $TTE $EQNR $NEE $DUK $D $AEP $SO $XEL $EXC $ED $PCG $PEG $PPL $EIX $AWK $WEC $CMS $NRG"  
[X Link](https://x.com/Biobeats99/status/1989474519489343558)  2025-11-14T23:24Z XXX followers, XXX engagements


"RBC SUPN US: Supernus Pharmaceuticals Initial Opinion Firing on all cylinders with trifecta of branded CNS launches: Initiate Buy $XX PO Full report in bio $SUPN $AXSM $RLMD $SAGE $CYT $LLY $BMY $BIIB $ABBV $JNJ $PFE $AMGN $VRTX $BMRN $SRPT $IONS $ALNY $ARWR $BLUE"  
[X Link](https://x.com/Biobeats99/status/1989479072125288901)  2025-11-14T23:42Z XXX followers, XXX engagements


"Goldman Sachs ALH US: Alliance Laundry Initial Opinion The (Speed) Queen of Laundry: initiate at Buy BUY Full report in bio $ALH $WHR $IR $LII $TT $CARR $AAON $LEG $MHK $MAS $FBIN $AWI $JCI $GNRC $SWK $HD $LOW $TSLA $GE $HON $EMR $ITW $DHR $MMM $ETN $ROK $CAT $DE $PH"  
[X Link](https://x.com/Biobeats99/status/1989479157190058484)  2025-11-14T23:42Z XXX followers, XXX engagements


"Cantor Fitzgerald CytomX Therapeutics is transforming from an underdog to a serious contender with growing confidence in the potential of its CX-2051 program. Full report in Bio $CTMX $RXRX $IMGN $ADAG $ABUS $BCAB $DAWN $KURA $NTLA $PRQR"  
[X Link](https://x.com/Biobeats99/status/1991556656191422772)  2025-11-20T17:18Z XXX followers, XXX engagements


"Cantor Fitzgerald Key highlights from the initiation webinar on DiaMedica Therapeutics showcase the company's promising pipeline and growth strategy. Full report in Bio $DMAC $RXRX $IMGN $ADAG $ABUS $BCAB $DAWN $KURA $NTLA $PRQR"  
[X Link](https://x.com/Biobeats99/status/1991559572654620960)  2025-11-20T17:29Z XXX followers, XXX engagements


"Barclays GE Healthcare acquires Intelerad for $XXX billion significantly expanding its cloud-based SaaS portfolio across multiple care settings; Equal Weight rating reiterated. Full report in Bio $GEHC $SIEM $PHG $BAX $MDT $BSX $RMD $EW $ABT $JNJ $DXCM $ISRG $ZBH $STE $TFX"  
[X Link](https://x.com/Biobeats99/status/1991900132019945785)  2025-11-21T16:02Z XXX followers, XXX engagements


"TD Cowen AZTA reports FY25 top and bottom line beat with initial FY26 revenue and adjusted EBITDA guidance exceeding expectations. Full report in Bio $AZTA $TMO $WAT $PKI $DHR $AVTR $ICLR $QLGN $BRKR $RGEN $NVCR $ST $REGN $VRTX $VCEL"  
[X Link](https://x.com/Biobeats99/status/1991923269629624780)  2025-11-21T17:34Z XXX followers, XXX engagements


"Piper Sandler Fourth quarter 2025 remains catalyst-rich with multiple key events expected through year-end for ACRV CAPR CRSP DYN FULC GLUE INO KYMR and MIST. Full report in Bio $ACRV $CAPR $CRSP $DYN $FULC $GLUE $INO $KYMR $MIST $BEAM $NTLA $EDIT $RXRX $IMGN $BCAX"  
[X Link](https://x.com/Biobeats99/status/1992827132301463662)  2025-11-24T05:26Z XXX followers, XXX engagements


"Mizuho Key opinion leaders express cautious optimism for Tinlarebant ahead of this week's Phase X data readout in Stargardt disease. Full report in Bio $BLTE $RETA $EYEN $OCUL $ADVM $RGNX $BEAM $NTLA $EDIT $CRSP $FDMT $RXRX $KYMR $IMGN $AGIO"  
[X Link](https://x.com/Biobeats99/status/1992988970779611377)  2025-11-24T16:09Z XXX followers, XXX engagements


"Citizens JMP Biotechnology sector poised for significant activity with multiple potential catalysts expected before year-end including clinical data readouts and regulatory decisions. Full report in Bio $KYMR $RXRX $DYN $CGON $NUVL $TARA $ACRV $SVRA $PRAX $AXSM"  
[X Link](https://x.com/Biobeats99/status/1993391934552129617)  2025-11-25T18:50Z XXX followers, XXX engagements


"Cantor Fitzgerald Analysis of short interest trends in biotechnology highlighting companies with high short interest facing near-term binary catalysts that could trigger significant moves. Full report in Bio $KYMR $RXRX $DYN $CGON $CLSD $NVO $AGIO $IMGN $BEAM $BCAX"  
[X Link](https://x.com/Biobeats99/status/1993777686838149599)  2025-11-26T20:23Z XXX followers, XXX engagements


"Wedbush NUVB's lead asset Safu represents a de-risked and advanced clinical candidate providing near-term value that outweighs the potential of earlier-stage DDC programs. Full report in Bio $NUVB $KYMR $RXRX $DYN $CGON $TARA $ACRV $SVRA $PRAX $AXSM $NUVL $BEAM $NTLA"  
[X Link](https://x.com/Biobeats99/status/1994111795787911186)  2025-11-27T18:31Z XXX followers, XXX engagements


"Jefferies BioMarin Pharmaceutical: The PDUFA delay for ASND is viewed as a procedural rather than clinical issue with limited fundamental impact. BUY rating maintained with confidence in the program's approval prospects in 1H26. Full report in Bio $BMRN $RARE $BGNE $UTHR"  
[X Link](https://x.com/Biobeats99/status/1994112833575858440)  2025-11-27T18:35Z XXX followers, XXX engagements


"Jefferies Monthly digest of the firm's most-read research reports and the top questions from institutional investors (the buyside) for November 2025 highlighting key sector trends and focal points. Full report in Bio $NUVL $ZYME $AGIO $VKTX $PCVX $TARA $CGON $AXSM $SVRA"  
[X Link](https://x.com/Biobeats99/status/1995526471092142406)  2025-12-01T16:12Z XXX followers, XXX engagements


"Piper Sandler BioInsights report highlights the ongoing revolution in RNA medicines showcasing technological advancements and therapeutic potential across key developers in the sector. Full report in Bio $ABBV $ALNY $AMGN $ARCT $ARWR $BIIB $BMRN $BMY $CAMP $CAPR $CRSP $DYN"  
[X Link](https://x.com/Biobeats99/status/1995526833513562417)  2025-12-01T16:14Z XXX followers, XXX engagements


"Jefferies Minerva receives FDA alignment on the design of a new pivotal Phase X trial for its therapy in negative symptoms of schizophrenia a positive regulatory step. Full report in Bio $NERV $SAGE $ALKS $ACAD $NBIX $SUPN $AXSM $SEEL $BCLI $MNKD $ATXI $JNJ $ABBV $BIIB"  
[X Link](https://x.com/Biobeats99/status/1995572181754069318)  2025-12-01T19:14Z XXX followers, XXX engagements


"Morgan Stanley December is set to be a critical month for the biopharma sector with multiple key catalysts including clinical trial results and regulatory decisions expected before year-end. Full report in Bio $KYMR $RXRX $DYN $NUVL $CGON $TARA $ACRV $SVRA $PRAX $AXSM $AGIO"  
[X Link](https://x.com/Biobeats99/status/1995881533031501917)  2025-12-02T15:43Z XXX followers, XXX engagements


"Bank of America Janux Therapeutics' price objective has been adjusted. The report frames the near-term catalyst for JANX007 as a binary outcome posing the question of which type of news investors should prepare for first. Full report in Bio $JANX $KYMR $CGON $IMGN $RXRX $DYN"  
[X Link](https://x.com/Biobeats99/status/1995882090861322476)  2025-12-02T15:45Z XXX followers, XXX engagements


"Bank of America Scholar Rock's manufacturing partner receives an expected FDA Warning Letter; Buy rating maintained as the issue is viewed as manageable and already anticipated. Full report in Bio $SRRK $KYMR $IMGN $RXRX $DYN $BEAM $NTLA $BCAX $CRSP $EDIT $BLUE $ARDS $BNTX"  
[X Link](https://x.com/Biobeats99/status/1995882786087932386)  2025-12-02T15:48Z XXX followers, XXX engagements


"Citizens JMP VTYX (OUTPERFORM PT): Interim Phase X data for recurrent pericarditis has been moved to a dedicated R&D Day in the first quarter of 2026. Full report in Bio $VTYX $KYMR $RXRX $DYN $CGON $TARA $ACRV $SVRA $PRAX $AXSM"  
[X Link](https://x.com/Biobeats99/status/1995919818562703749)  2025-12-02T18:15Z XXX followers, XXX engagements


"TD Cowen RVMD named a top pick for 2026 highlighted for its revolutionary approach to treating RAS-positive solid tumors representing a significant market opportunity. Full report in Bio $RVMD $KYMR $RXRX $DYN $CGON $NUVL $TARA $ACRV $SVRA $PRAX $AXSM $BEAM"  
[X Link](https://x.com/Biobeats99/status/1996298941499846920)  2025-12-03T19:22Z XXX followers, XXX engagements


"Jefferies Crescent's strategic partnership with Kelun represents a major step forward providing validation resources and potential acceleration for its clinical pipeline. Full report in Bio $CBIO $RXRX $KYMR $DYN $CGON $TARA $ACRV $SVRA $PRAX $AXSM $NUVL $BEAM $NTLA"  
[X Link](https://x.com/Biobeats99/status/1996814600625705361)  2025-12-05T05:31Z XXX followers, XXX engagements


"Jefferies Praxis Precision Medicines reports two positive clinical developments: one in Essential Tremor and another in a rare form of epilepsy reinforcing its pipeline's potential. BUY rating maintained. Full report in Bio $PRAX $AXSM $SAGE $SEEL $BIIB $NBIX $ACAD $SUPN"  
[X Link](https://x.com/Biobeats99/status/1996815026435620875)  2025-12-05T05:32Z XXX followers, XXX engagements


"TD Cowen HALO named a top pick for 2026 with confidence centered on the strategic value and commercial potential of its ENHANZE drug delivery technology platform. Full report in Bio $HALO $RXRX $KYMR $CGON $DYN $TARA $ACRV $SVRA $PRAX $AXSM $NUVL $BEAM $ARWR $ALNY $BMRN"  
[X Link](https://x.com/Biobeats99/status/1997006620275233176)  2025-12-05T18:14Z XXX followers, XXX engagements


"Wolfe Research Summary ahead of a key binary event for Kymab (KYMR) this Monday December 8th. The event likely a major clinical data readout or regulatory decision is expected to cause significant stock volatility. Full report in Bio $KYMR $RXRX $DYN $CGON $NUVL $TARA"  
[X Link](https://x.com/Biobeats99/status/1997322466947948843)  2025-12-06T15:09Z XXX followers, XXX engagements


"Finger On The Pulse Full report in Telegram(in title)👆 $SMID $MBRX $OGEN $BCDA $TFFP $GTBP $LIXT $CBI $AZTR $VAXX $RAIN $AIMD $HEPA $TRVN $RVV $SNGX $DCL $FNCH $SONN $XCUR $APLIF $ADIL $ALLR $PNT $PRTG $GNPX $PHIL $PALI $ONCO $ENSC $APVO $TRA $CING $INFI $DMTK $BIOS $NEXI"  
[X Link](https://x.com/Biobeats99/status/1904174739192439036)  2025-03-24T14:13Z XXX followers, 2692 engagements


"Needham HRMY reports positive results for Pitolisant GR supporting a planned NDA submission in early 2026. BUY rating maintained with $XX price target. Full report in Bio $HRMY $AXSM $JAZZ $AVDL $SUPN $SAGE $SEEL $BCLI $MNKD $PRTA"  
[X Link](https://x.com/Biobeats99/status/1992991405673746842)  2025-11-24T16:19Z XXX followers, XXX engagements


"Cantor Fitzgerald Analysis of Arrowhead's pooled baseline data from its Phase X SHTG trial indicates a well-characterized patient population reducing clinical risk ahead of topline results. Positive stock outlook maintained. Full report in Bio $ARWR $ALNY $IONS $VRTX $NUVL"  
[X Link](https://x.com/Biobeats99/status/1996815371727458668)  2025-12-05T05:34Z XXX followers, XXX engagements


"TD Cowen ASH 2025 data and a clear 2026 catalyst path signal a major upcoming growth phase ("Boom") for next-generation IKZF1/3 degraders in multiple myeloma. Full report in Bio $CCCC $KYMR $RXRX $CGON $DYN $TARA $ACRV $SVRA $PRAX $AXSM $NUVL $BEAM $NTLA $CRSP $BMY $AMGN"  
[X Link](https://x.com/Biobeats99/status/1997007069996573091)  2025-12-05T18:16Z XXX followers, XXX engagements


"Jefferies Structure Therapeutics' robust Phase X data for its oral GLP-1 receptor agonist solidifies its profile as a Phase 3-ready asset in the competitive obesity market. Full report in Bio $GPCR $LLY $NVO $AMGN $ALT $VKTX $CORT $BIIB $MNKD $KYMR $RXRX $CGON $DYN $AXSM"  
[X Link](https://x.com/Biobeats99/status/1998084868396531816)  2025-12-08T17:38Z XXX followers, XXX engagements


"Piper Sandler Cogent Biosciences reports a 'hat trick' of positive updates for bezuclastinib: positive data in Advanced Systemic Mastocytosis (AdvSM) and deepening responses in Non-Advanced SM reinforcing its best-in-class potential. Full report in Bio $COGT $KYMR $RXRX $DYN"  
[X Link](https://x.com/Biobeats99/status/1998114207342932258)  2025-12-08T19:35Z XXX followers, XXX engagements